SSLF-CSI: Sacrospinous Ligament Fixation With Conventional Surgical Instruments in Chinese Apical Prolapse Female Patients

Sponsor
Peking Union Medical College Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT03782285
Collaborator
First Hospitals affiliated to the China PLA General Hospital (Other), Shanghai First Maternity and Infant Hospital (Other), The Second Hospital of Anhui Medical University (Other), Shanxi Provincial Maternity and Children's Hospital (Other), Foshan Women and Children's Hospital (Other), Suzhou Municipal Hospital (Other), Chongqing Maternal and Child Health Hospital (Other), Hangzhou Maternal and Child Health Hospital (Other), Beijing Obstetrics and Gynecology Hospital (Other), Peking Union Medical College (Other), St. Francis Hospital, Chicago, USA (Other), University of Texas, Southwestern Medical Center at Dallas (Other)
100
9
9.3
11.1
1.2

Study Details

Study Description

Brief Summary

SSLF is typically a suture-based attachment of the vaginal apex to the sacrospinous ligament, either unilaterally or bilaterally. It is usually accomplished with specially designed equipment in English-language scientific literature. However, these instruments either reusable or disposable are relatively expensive and difficult in accessibility, and are not yet widely applied around China. Typical Asian smaller pelvis offers us an optional repair procedure with conventional surgical instruments instead of special instrument.

Condition or Disease Intervention/Treatment Phase
  • Procedure: sacrospinous Ligament Fixation

Detailed Description

Apical prolapse is defined as descent of the uterus and cervix, the cervix alone, or the post-hysterectomy vaginal cuff down to the hymen, lower vagina, or past the introitus. Among 684,250 POP procedures that were performed in 15 Organization for Economic Co-operation and Development (OECD) countries in 2012, apical compartment repairs represented 20% of these procedures. Sacrospinous ligament suspension (SSLF) as a typical native tissue repair procedure is one of the most widely used vaginal procedures for correcting apical prolapse. SSLF is typically a suture-based attachment of the vaginal apex to the sacrospinous ligament, either unilaterally or bilaterally usually with specially designed equipment such as Deschamps ligature carrier or Miya hook. However, these instruments are expensive and are not yet widely applied in China. Typical Asian smaller pelvis offers us an optional repair procedure with conventional surgical instruments instead of special instrument. Previous pilot study from Peking Union Medical College Hospital showed promising curative results with conventional surgical instruments in Chinese female patients. The investigation may show us a feasible, economic and effective modified procedure for Asian patients with medium compartment prolapse.

This is a multi-center, prospective clinical trial. Previous studies using conventional surgical instruments for 1-year follow-up showed objective cure rate was 98%, subjective satisfaction was 94%, Considering that the objective cure rate may decrease in multicenter trials, it is assumed that the objective cure rate of multicenter trials can reach 95%. When the sample size is at least 79 patients, 80% of the test efficiency can verify that the objective cure rate is higher than the target value when the bilateral α=0.05. The missing rate was about 10%. The incidence of SSLF failure requiring other operations method due to deep pelvic cavity and unsatisfactory exposure by conventional instruments was about 5%. The final number of cases included in this study should be 100 cases. Ischial spinous fascia fixation (ISFF) will be the replacement procedure if SSLF will not be accomplished by conventional surgical instruments due to unsatisfactory exposure of spinous fascia. The research units will collect perioperative data and complete unified format case report form (CRF) for all selected patients for further analysis. A total of at most 9 months will be required to complete the study after starting up.

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
100 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Sacrospinous Ligament Fixation With Conventional Surgical Instruments in Chinese Apical Prolapse Female Patients: a Multi-center Prospective Clinical Trial
Actual Study Start Date :
Nov 23, 2018
Anticipated Primary Completion Date :
Aug 1, 2019
Anticipated Study Completion Date :
Sep 1, 2019

Outcome Measures

Primary Outcome Measures

  1. Success rate of SSLF with conventional instruments [up to 36 months after operation]

    Symptomatic prolapse below grade II occurred at 3 months after operation, and the severest indication point in POP-Q evaluation was taken as the criterion. No vaginal swelling sensation, that is answer "no" for PFDI-20 Questionnaire Question 3, "Do you often see or feel vaginal tumors come out?". The patient's self-perception symptoms is improved or improved significantly, that is answer 1 or 2 for the PGI-C questionnaire. There is no need of further treatment for prolapse, such as reoperation or pessary. Pelvic MRI evaluation on postoperative 3 months follow-up

Secondary Outcome Measures

  1. Postoperative recurrence [from 3 months after operation up to 36 months after operation]

    Evaluation on the prolapse of the anterior, middle and posterior pelvic confirms POP-Q II degrees and above.

  2. visual analogue scales [within 3 days after operation]

    postoperative pain evaluation esp. hip pain by visual analogue scales (VAS). Visual Analogue Scale (VAS) is a self-report measure consisting simply of a 10 centimeter line with a statement at each end representing one extreme of the dimension being measured (most often intensity of pain)

  3. symptomatic improvement using validated instruments(PFIQ-7) [up to 36 months after operation]

    Relief of symptoms using validated instruments, pelvic floor impact questionnaire short form 7(PFIQ-7)。PFIQ-7 scores 0-300, the higher the severer negative influence on patient.

  4. symptomatic improvement using validated instruments(PFDI-20) [up to 36 months after operation]

    Relief of symptoms using validated instruments, pelvic floor distress inventory short form 20(PFDI-20), PFDI-20 scores 0-300, the higher the severer negative influence on patient.

  5. symptomatic improvement using validated instruments(PISQ-12) [up to 36 months after operation]

    Relief of symptoms using validated instruments, Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire short form(PISQ-12), PISQ-12 scores 0-48, the higher, the severer negative influence on patient.

  6. symptomatic improvement using patient global impression of change (PGI-C) [up to 36 months after operation]

    Relief of symptoms using patient global impression of change (PGI-C), PGI-C scores 1-7, the higher, the the severer negative influence on patient.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Women with apical prolapse with POP-Q III or IV

  2. Unilateral (all sutured to right sacrospinous ligament) SSLF is planned,while with vaginal hysterectomy, anterior/posterior vaginal wall repair or mid-urethral suspension could be performed simultaneously.

  3. Women who have been eligible for long-term follow-up.

  4. Women who agreed to participate in the study and signed informed consent.

Exclusion Criteria:
  1. Women who have surgical history for prolapse

  2. Women who have contraindication for surgical procedure

  3. Women who are unable to comply with the study procedures

Contacts and Locations

Locations

Site City State Country Postal Code
1 2nd Affiliated hospital of Anhui Medical college Hefei Anhui China 230041
2 1st Affiliated hospital of PLA general hospital Beijing Beijing China 100037
3 Peking Union Medical College Hospital Beijing Beijing China 100730
4 Chongqing Women's and Children's Hospital Chongqing Chongqing China 400021
5 Foshan Women's and Children's Hospital Foshan Guangdong China 528000
6 Suzhou City Hospital Suzhou Jiangsu China 215008
7 Shanghai First Maternity and Infant Hospital Shanghai Shanghai China 200040
8 Shan'xi Province Women's and Children's Hospital Taiyuan Shanxi China 300013
9 Hangzhou Women's and Children's Hospital Hangzhou Zhejiang China 310008

Sponsors and Collaborators

  • Peking Union Medical College Hospital
  • First Hospitals affiliated to the China PLA General Hospital
  • Shanghai First Maternity and Infant Hospital
  • The Second Hospital of Anhui Medical University
  • Shanxi Provincial Maternity and Children's Hospital
  • Foshan Women and Children's Hospital
  • Suzhou Municipal Hospital
  • Chongqing Maternal and Child Health Hospital
  • Hangzhou Maternal and Child Health Hospital
  • Beijing Obstetrics and Gynecology Hospital
  • Peking Union Medical College
  • St. Francis Hospital, Chicago, USA
  • University of Texas, Southwestern Medical Center at Dallas

Investigators

  • Study Chair: Lan Zhu, Peking Union Medical College Hospital
  • Principal Investigator: Yongxian Lu, 1st Affiliated hospital of PLA general hospital
  • Principal Investigator: Zhiyuan Dai, Shanghai First Maternity and Infant Hospital
  • Principal Investigator: Wenyan Wang, 2nd Affiliated hospital of Anhui Medical college
  • Principal Investigator: Zhaoai Li, Shan'xi Province Women's and Children's Hospital
  • Principal Investigator: Yuling Wang, Foshan Women's and Children's Hospital
  • Principal Investigator: Shunyu Hou, Suzhou City Hospital
  • Principal Investigator: Lubin Liu, Chongqing Women's and Children's Hospital
  • Principal Investigator: Xiangjuan Li, Hangzhou Women's and Children's Hospital
  • Principal Investigator: Le Ma, Beijing Obstetrics and Gynecology Hospital
  • Principal Investigator: Tao Xu, Statistics Department of Peking Union Medical College
  • Principal Investigator: Joseph Schaffer, UT Southwestern Medical Center
  • Principal Investigator: Marko J Jachtorowycz, Saint Francis Memorial Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Peking Union Medical College Hospital
ClinicalTrials.gov Identifier:
NCT03782285
Other Study ID Numbers:
  • PekingUnion:SSLF-CSI
First Posted:
Dec 20, 2018
Last Update Posted:
Dec 20, 2018
Last Verified:
Dec 1, 2018
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Peking Union Medical College Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 20, 2018